Rosetta Genomics Stock Performance

Rosetta Genomics Relative Risk vs. Return Landscape

If you would invest  0.01  in Rosetta Genomics on November 10, 2025 and sell it today you would earn a total of  0.01  from holding Rosetta Genomics or generate 100.0% return on investment over 90 days. Rosetta Genomics is currently producing 1.5873% returns and takes up 12.5988% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Rosetta, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.Assuming the 90 days horizon Rosetta Genomics is expected to generate 15.51 times more return on investment than the market. However, the company is 15.51 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Rosetta Genomics Target Price Odds to finish over Current Price

Assuming the 90 days horizon the pink sheet has the beta coefficient of 2.13 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Rosetta Genomics will likely underperform. Moreover Rosetta Genomics has an alpha of 1.3352, implying that it can generate a 1.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Rosetta Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rosetta Genomics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.0001 12.60 Details

Intrinsic Valuation Low Real High 0.00 0.0002 12.60 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rosetta Genomics. Your research has to be compared to or analyzed against Rosetta Genomics' peers to derive any actionable benefits. When done correctly, Rosetta Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rosetta Genomics.

Rosetta Genomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Rosetta Genomics is not an exception. The market had few large corrections towards the Rosetta Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rosetta Genomics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rosetta Genomics within the framework of very fundamental risk indicators.

Rosetta Genomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rosetta Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rosetta Genomics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Rosetta Genomics Fundamentals Growth

When running Rosetta Genomics' price analysis, check to measure Rosetta Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rosetta Genomics is operating at the current time. Most of Rosetta Genomics' value examination focuses on studying past and present price action to predict the probability of Rosetta Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rosetta Genomics' price. Additionally, you may evaluate how the addition of Rosetta Genomics to your portfolios can decrease your overall portfolio volatility.